LIPRO Dietary capsules pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested a product labelled LIPRO Dietary capsules and found that:
the capsules contain the undeclared substances sibutramine and diphenhydramine.
Consumers are advised that sibutramine is a prescription-only substance in Australia. Sibutramine (which was the active ingredient in Reductil) was withdrawn in October 2010 after a study showed an increased risk of major cardiac events. Diphenhydramine is a pharmacy only substance and used as an antihistamine.
The supply of LIPRO Dietary capsules containing undisclosed sibutramine and diphenhydramine is illegal.
LIPRO Dietary capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia may have bought the product online.
Information for consumers
Stop taking LIPRO Dietary capsules and take any remaining capsules to your local pharmacy for safe disposal.
If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with the Australian Border Force (ABF) to help stop future shipments of LIPRO Dietary capsules from entering Australia.
If these capsules are found at the border by the ABF they will be seized and destroyed.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.